Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 177

    1.

    Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis.

    D'souza Y, Short CD, McLeod D, Bonshek RE.

    Br J Ophthalmol. 2008 Jul;92(7):950-3.PMID: 18577648 [PubMed - indexed for MEDLINE]Related articles

    2.

    Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").

    Colville D, Guymer R, Sinclair RA, Savige J.

    Am J Kidney Dis. 2003 Aug;42(2):E2-5.PMID: 12900843 [PubMed - indexed for MEDLINE]Related articles

    3.

    Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II).

    Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M.

    Eur J Ophthalmol. 1991 Jan-Mar;1(1):17-22.PMID: 1821193 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Ocular impairment during type II membranoproliferative glomerulonephritis]

    Lahbil D, Rais L, Hamdani M, El Kettani A, Laouissi N, Zaghloul K, Amraoui A.

    J Fr Ophtalmol. 2002 Nov;25(9):949-54. French. PMID: 12515943 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.

    O'Brien C, Duvall-Young J, Brown M, Short C, Bone M.

    Br J Ophthalmol. 1993 Dec;77(12):778-80.PMID: 8110672 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.

    Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA.

    Am J Ophthalmol. 1993 Oct 15;116(4):410-3.PMID: 8213970 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green]

    Parrat E, Arndt CF, Labalette P, Boulanger E, Hache JC, Constantinides G, Dequiedt P.

    J Fr Ophtalmol. 1997;20(6):430-8. French. PMID: 9296039 [PubMed - indexed for MEDLINE]Related articles

    8.

    Retinal changes associated with type 2 glomerulonephritis.

    McAvoy CE, Silvestri G.

    Eye (Lond). 2005 Sep;19(9):985-9.PMID: 15375355 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II]

    Framme C, Herboth T, Roider J, Laqua H.

    Klin Monbl Augenheilkd. 1998 Oct;213(4):252-3. German. PMID: 9848073 [PubMed - indexed for MEDLINE]Related articles

    10.

    Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.

    Shenoy R, McCilvenny S.

    Eur J Ophthalmol. 2006 Jul-Aug;16(4):634-6.PMID: 16952110 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.

    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.

    Ophthalmology. 2008 Sep;115(9):1474-9, 1479.e1-6. Epub 2008 May 27.PMID: 18502512 [PubMed - indexed for MEDLINE]Related articles

    12.

    Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.

    Leys A, Proesmans W, Van Damme-Lombaerts R, Van Damme B.

    Pediatr Nephrol. 1991 Mar;5(2):189-92. Erratum in: Pediatr Nephrol 1991 May;5(3):364. PMID: 2031833 [PubMed - indexed for MEDLINE]Related articles

    13.

    Drusen classification in bilateral drusen and fellow eye of exudative age-related macular degeneration.

    Hamada S, Jain S, Sivagnanavel V, Patel N, Chong NV.

    Eye (Lond). 2006 Feb;20(2):199-202.PMID: 15746948 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV.

    Richter-Mueksch S, Stur M, Stifter E, Radner W.

    Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):154-62. Epub 2005 Jul 27.PMID: 16047185 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fundus changes in chronic membranoproliferative glomerulonephritis type II.

    Michielsen B, Leys A, Van Damme B, Missotten L.

    Doc Ophthalmol. 1990-1991;76(3):219-29.PMID: 2103524 [PubMed - indexed for MEDLINE]Related articles

    16.

    Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.

    Maguire MG, Alexander J, Fine SL; Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.

    Ophthalmology. 2008 Sep;115(9):1468-73, 1473.e1-2. Epub 2008 May 16.PMID: 18486222 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.

    Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M.

    Graefes Arch Clin Exp Ophthalmol. 1991;229(5):406-10.PMID: 1937071 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Assessment of the clinical and functional results of laser coagulation of retinal drusen in the central zone of the eye grounds]

    Neroev VV, Lysenko VS, Babaeva AM, Tsapenko IV.

    Vestn Oftalmol. 2007 Sep-Oct;123(5):23-5. Russian. PMID: 18078053 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glycoproteins of drusen and drusen-like lesions.

    D'souza Y, Jones CJ, Bonshek R.

    J Mol Histol. 2008 Feb;39(1):77-86. Epub 2007 Sep 11.PMID: 17846903 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data